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The establishment of protective humoral immunity is dependent on the ability of 
mature B cells to undergo antibody gene diversification while adjusting to the 
physiological stressors induced by activation with the antigen. Mature B cells 
diversify their antibody genes by class switch recombination (CSR) and somatic 
hypermutation (SHM), which are both dependent on efficient induction of activation-
induced cytidine deaminase (AID). Here, we identified PDGFA-associated protein 1 
(Pdap1) as an essential regulator of cellular homeostasis in mature B cells. Pdap1 
deficiency leads to sustained expression of the integrated stress response (ISR) 
effector activating transcription factor 4 (Atf4) and induction of the ISR transcriptional 
program, increased cell death, and defective AID expression. As a consequence, 
loss of Pdap1 reduces germinal center B cell formation and impairs CSR and SHM. 
Thus, Pdap1 protects mature B cells against chronic ISR activation and ensures 
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The diversity of our immunoglobulin (Ig) gene repertoire is the result of antibody 
diversification reactions occurring at different stages of B lymphocytes development 
(Dudley et al., 2005; Methot and Di Noia, 2017). Developing B cells in the bone 
marrow randomly assemble different gene segments (known as variable (V), diversity 
(D) and joining (J) genes) at the Ig heavy (Igh) and light (Igl) chain loci via V(D)J 
recombination (Roth, 2014; Dudley et al., 2005). This process generates unique 
antibody gene receptors with the potential to collectively recognize a formidable 
number of antigens. Mature B cells further diversify their Ig genes in the periphery via 
somatic hypermutation (SHM) and class switch recombination (CSR) (Pavri and 
Nussenzweig, 2011; Methot and Di Noia, 2017). SHM introduces point mutations into 
the variable V(D)J region of the Ig genes to generate higher-affinity variants. CSR 
recombines the Igh constant (C) regions to replace the C portion of the IgM heavy 
chain with one of alternative isotypes (IgG, IgA and IgE), thus diversifying the Ig 
effector function. SHM and CSR are crucial to mount protective humoral responses, 
as evidenced by primary human immunodeficiency syndromes that are caused by 
defects in these reactions (Durandy et al., 2013).  
 
SHM and CSR are both dependent on the B cell-specific enzyme activation-induced 
cytidine deaminase (AID) (Revy et al., 2000; Muramatsu et al., 2000). AID 
deaminates cytosine residues to uracil in single-stranded DNA stretches at the 
variable regions of both Igh and Igl loci during SHM, and within special recombining 
elements (switch (S) regions) of the Igh during CSR (Bransteitter et al., 2003; 
Chaudhuri et al., 2003; Petersen-Mahrt et al., 2002; Pham et al., 2003; Sohail et al., 
2003; Ramiro et al., 2003; Dickerson et al., 2003; Matthews et al., 2014; Methot and 
Di Noia, 2017). The resulting U:G mismatches are differentially processed to 
generate either mutations in the variable regions or DNA breaks in the S regions 
(Peled et al., 2008; Methot and Di Noia, 2017; Matthews et al., 2014). AID expression 
is induced when resting mature (naïve) B cells are activated by the antigen and T-cell 
interactions (Zhou et al., 2003; Sayegh et al., 2003; Gonda et al., 2003; Cunningham 
et al., 2004; Dedeoglu et al., 2004; Muramatsu et al., 1999). Antigen stimulation 
reprograms naïve B cells to exit the quiescent state, expand their cellular biomass, 
and undergo a proliferative burst within transient and anatomically distinct structures 
in secondary lymphoid organs called germinal centers (GCs) (Cyster and Allen, 
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2019; Victora and Nussenzweig, 2012). AID expression peaks in GC B cells 
(Cattoretti et al., 2006; Crouch et al., 2007; Roco et al., 2019). The GC reaction 
represents the end stage of B cell development as GC B cells differentiate into 
memory B cells or long-lived plasma cells that secrete high affinity antibodies.  
 
The integrated stress response (ISR) is a homeostatic program activated by a variety 
of physiological and pathological stresses to promote cellular recovery (Ron and 
Walter, 2007; Pakos-Zebrucka et al., 2016). These stresses include both cell intrinsic 
and extrinsic stimuli, such as endoplasmic reticulum (ER) stress, mitochondrial 
dysfunction, hypoxia, and amino acid deprivation (Quirós et al., 2017; Harding et al., 
2003; Dever et al., 1992; Rzymski et al., 2010; Ye et al., 2010; Harding et al., 1999). 
All forms of stress converge into the phosphorylation of the alpha subunit of the 
eukaryotic translation initiation factor 2 (eIF2a) on serine 51 (Donnelly et al., 2013). 
This event causes a reduction in global protein synthesis while allowing the 
preferential translation of few selected genes including the ISR effector activating 
transcription factor 4 (Atf4) (Hinnebusch, 2000; Harding et al., 2000; Scheuner et al., 
2001; Lu et al., 2004). Atf4 induces the transcriptional upregulation of stress-
responsive genes and rewires cell metabolism towards the recovery of cellular 
homeostasis (Harding et al., 2003). The inhibition of general protein translation in the 
early stage of the ISR is followed by a later phase of translational recovery, which 
restores protein synthesis once the stress is resolved to support cell survival 
(Brostrom and Brostrom, 1998; Novoa et al., 2003; Kojima et al., 2003; Marciniak et 
al., 2004; Brostrom et al., 1989; Ma and Hendershot, 2003).  
 
Although the ISR is an adaptive program meant to restore cellular homeostasis and 
to promote cell survival, under conditions of severe or prolonged stress, it induces 
cell death by activating pro-apoptotic pathways (Zou et al., 2008; Puthalakath et al., 
2007; Teske et al., 2013; Wang et al., 2009; Ohoka et al., 2005; Gupta et al., 2012; 
Hiramatsu et al., 2014; Marciniak et al., 2004). Furthermore, the sustained protein 
synthesis during chronic stress causes proteotoxicity and leads to cell death (Han et 
al., 2013; Krokowski et al., 2013). Here, we identified PDGFA-associated protein 1 
(Pdap1) as an essential regulator of mature B cell physiology that functions by 
countering chronic activation of the ISR. Pdap1 ablation in mature B cells causes 
sustained expression of Atf4, long-term induction of the ISR transcriptional program, 
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and cell death. Furthermore, Pdap1 is essential for efficient induction of AID 
expression and physiological levels of CSR and SHM.  
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Pdap1 is required for efficient CSR 
To identify novel modulators of mature B cell physiology, we performed loss-of-CSR 
screens via somatic gene targeting by CRISPR-Cas9 in the B cell lymphoma line 
CH12. CH12 cells share several properties of resting B cells, and have been 
employed to study key aspects of late B cell differentiation, including B cell activation, 
antibody diversification by CSR, and immunoglobulin secretion (Arnold et al., 1983; 
Stockdale et al., 1987; Wiest et al., 1990; Corley et al., 1985; Bishop and Haughton, 
1986; Nakamura et al., 1996; Ovnic and Corley, 1987; Fagone et al., 2007; Gass et 
al., 2002; Dufort et al., 2014; LoCascio et al., 1984; Locascio et al., 1984). Upon 
cytokine stimulation, CH12 cells express AID and undergo CSR to IgA with high 
efficiency (Nakamura et al., 1996). CRISPR-Cas9-mediated deletion of factors 
required for CSR reduces the efficiency of isotype switching in this cell line (Delgado-
Benito et al., 2018). Among all tested candidates, targeting of Pdap1 resulted in a 
considerable reduction of CSR (Fig. 1, A and B). To confirm the results of the loss-of-
CSR screen, we generated Pdap1-deficient CH12 clonal derivative cell lines, which 
included both indel knock-out (Pdap1-/-) and in-frame deletion mutant (Pdap1mut) 
clones (Fig. 1, C and D). In agreement with the CSR defect observed in bulk CH12 
cultures, CSR was impaired in Pdap1-deficient clonal derivatives (Fig. 1E). We 
concluded that Pdap1 supports efficient CSR in CH12 cells. 
 
Pdap1 is a 28 kDa phosphoprotein highly conserved in vertebrates. It was originally 
identified as a casein kinase II substrate and a weak interactor of platelet-derived 
growth factor (PDGF)-A (Shen et al., 1996; Fischer and Schubert, 2002). More 
recently, Pdap1 was described as an RNA-binding protein in several RNA-protein 
interactome studies (Castello et al., 2012, 2016; Trendel et al., 2019; Baltz et al., 
2012; Iadevaia et al., 2020). However, the precise cellular function(s) of Pdap1 and 
its involvement in adaptive immunity are unknown. 
 
To verify Pdap1 involvement in CSR in vivo and elucidate the underlying mechanism, 
we generated a mouse model bearing a conditional Pdap1F allele, and bred it to 
Cd19Cre/+ mice to specifically ablate Pdap1 expression at the early stages of B cell 
differentiation (Rickert et al., 1997) (Fig. S1, A and B). B cell development was 
largely unaffected in Pdap1F/FCd19Cre/+ mice (Fig. S1, C and D), indicating that 
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Pdap1 is dispensable for V(D)J recombination and early B cell differentiation. 
However, we observed a pronounced reduction in the number of splenic resting 
mature B cells (Fig. S1E). To confirm the intrinsic CSR defect caused by Pdap1-
deficiency, we isolated resting splenocytes from Pdap1F/FCd19Cre/+ mice and 
monitored their capability to undergo CSR upon in vitro stimulation. We assessed 
CSR under conditions that induce switching to IgG1, IgG3, IgG2b, and IgA, and 
found that Pdap1-deficient B cells displayed reduced levels of CSR for all tested 
isotypes (Fig. 2, A to D). Western blot analysis confirmed the near complete 
abrogation of Pdap1 expression in these cells (Fig. 2E). Altogether, these data 
indicate that Pdap1 is required for efficient CSR in primary B cells irrespective of the 
stimulation condition. 
 
Pdap1 supports physiological levels of AID expression 
CSR is dependent on cell proliferation (Hasbold et al., 1998; Hodgkin et al., 1996; 
Deenick et al., 1999; Hasbold et al., 1999). To determine if the reduced CSR 
efficiency of Pdap1-deficient B cells is caused by an underlying defect in cell 
proliferation, we monitored the proliferation capabilities of splenocytes cultures by cell 
tracking dye dilution. The CellTrace Violet dilution profiles of Pdap1F/FCd19Cre/+ B 
cells were indistinguishable from the control counterparts under all stimulation 
conditions (Fig. S2, A to D). Furthermore, class switching was reduced in Pdap1-
deficient B cells independently of the number of cell divisions (Fig. S2E). We 
concluded that Pdap1 is dispensable for B cell proliferation, and that the CSR defect 
of Pdap1F/FCd19Cre/+ B cells is not due to reduced proliferation capabilities. 
 
The efficiency of CSR is directly linked to the levels of AID expression (Dorsett et al., 
2008; Takizawa et al., 2008; Teng et al., 2008). Furthermore, AID targeting is 
dependent on non-coding transcription across the S regions (germline transcription, 
GLT), which exposes single-stranded DNA stretches that are the substrate of AID-
mediated deamination (Chaudhuri et al., 2003; Dickerson et al., 2003; Ramiro et al., 
2003). Therefore, we monitored Aicda mRNA and GLT levels in activated B cells by 
quantitative reverse transcription PCR (RT-qPCR) analysis. We found that Aicda 
transcript levels were consistently reduced in Pdap1F/FCd19Cre/+ B cells compared to 
controls across all stimulation conditions (Fig. 3A). Transcription of donor Sµ region 
was not affected by Pdap1 deletion (Fig. 3B), whereas acceptor S region 
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transcription exhibited a varied phenotype, with reduced levels of GLTg1 and GLTa, 
and minimally affected or unaltered expression for GLTg3 and GLTg2b, respectively 
(Fig. 3C). Analogously, analysis of Aicda and germline transcripts in Pdap1-deficient 
CH12 cell lines showed reduced Aicda mRNA levels but unaffected Sµ and Sa 
region transcription (Fig. S3, A to C). In agreement with the reduction of Aicda 
mRNA, Pdap1-deficient splenocytes expressed lower levels of AID protein upon 
activation compared to control cells (Fig. 3D). 
 
To confirm that the reduced CSR efficiency of Pdap1F/FCd19Cre/+ B cells is due to 
lower levels of AID expression, we assessed whether overexpression of AID in these 
cells could rescue the CSR defect. To this end, we transduced Cd19Cre/+ and 
Pdap1F/FCd19Cre/+ splenocytes with a construct expressing AID fused to the 
hormone-binding domain of the modified estrogen receptor (AID-ER). Provision of 4-
hydroxytamoxifen (4-HT) induces the translocation of the cytoplasm-accumulated 
AID-ER fusion protein into the nucleus and initiates CSR. We found that 4-HT 
addition rescued the CSR defect of Pdap1F/FCd19Cre/+ cells to levels equivalent to 
AID-ER-reconstituted Aicda-/- splenocytes in cultures stimulated to undergo CSR to 
IgG2b but not in cells stimulated to undergo CSR to IgG1 (Fig. 3E). This result is in 
agreement with the additional defect in acceptor GLT expression exhibited by 
Pdap1F/FCd19Cre/+ B cells switching to IgG1 (Fig. 3C). We concluded that Pdap1-
deficiency impairs AID expression, and as a consequence, CSR.  
 
Pdap1 has been recently identified in RNA-protein capture experiments as an RNA 
binding protein (Castello et al., 2012, 2016; Trendel et al., 2019; Baltz et al., 2012; 
Iadevaia et al., 2020). Therefore, we considered the possibility that Pdap1 might 
contribute to the post-transcriptional regulation of AID expression. To test this 
hypothesis, we treated Cd19Cre/+ and Pdap1F/FCd19Cre/+ splenocytes cultures with 
Actinomycin D to inhibit the de novo transcription of AID, and measured Aicda mRNA 
decay by qRT-PCR. We found that depletion of Pdap1 did not affect the kinetics of 
Aicda mRNA degradation (Fig. S4, A and B). This result indicates that Pdap1 is 
dispensable for Aicda transcript stability, decapping and deadenylation since a defect 
in any of these processes would result in accelerated decay. Next, we monitored 
Aicda transcript splicing. Several splice variants for AID have been identified, with the 
full-length transcript being the only splice isoform encoding a functional AID protein 
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(van Maldegem et al., 2009; Sala et al., 2015; van Maldegem et al., 2010). To assess 
whether Pdap1 modulates Aicda splicing, we performed RNA next-generation 
sequencing (RNA-Seq) of activated B cells induced to undergo CSR to either IgG1 or 
IgG2b, and analysed the pattern of Aicda exon usage. We found no difference in the 
profile of Aicda exon usage between Cd19Cre/+ and Pdap1F/FCd19Cre/+ B cells (Fig. 
S4C). Furthermore, primary Aicda transcript levels in Pdap1F/FCd19Cre/+ splenocytes 
were reduced compared to Cd19Cre/+ cells to the same extent observed for the full-
length spliced product (Fig. S4D and 3A). We concluded that ablation of Pdap1 does 
not affect Aicda mRNA splicing. 
 
Altogether, these findings indicate that Pdap1 supports physiological levels of AID 
expression, and that the CSR defect of Pdap1-deficient B cells is caused, at least in 
part, by impaired induction of AID expression following activation rather than a defect 
in Aicda post-transcriptional regulation. 
 
Pdap1 deficiency in B cells induces the Atf4 stress response transcriptional 
program 
To define the mechanism responsible for the defective induction of AID expression in 
Pdap1-deficient cells, we compared the transcriptome profiles of Cd19Cre/+ and 
Pdap1F/FCd19Cre/+ splenocytes stimulated with either LPS and IL-4, or LPS, BAFF, 
and TGFb (Table S1). The use of two stimulation conditions allowed us to zoom in 
common differentially-regulated pathways, and added a temporal dimension to the 
experiment since LPS-BAFF-TGFb-stimulated splenocytes proliferate faster than 
LPS-IL-4-activated ones (Fig. S2F). To identify differentially expressed genes, we set 
the significance level of false discovery rate (FDR) to < 0.05 (Fig. 4A). The number of 
differentially regulated genes was higher in LPS-IL-4-stimulated cultures than in LPS-
BAFF-TGFb-activated cells (1227 versus 173). Furthermore, the number of genes 
upregulated in Pdap1F/FCd19Cre/+ was considerably higher than the downregulated 
ones in LPS-BAFF-TGFb-stimulated cultures (124 up- versus 49 downregulated), but 
was evenly distributed among the two categories in the LPS-IL-4 stimulation 
condition (561 up- versus 666 downregulated).  
 
Pathway enrichment analysis of the downregulated genes in Pdap1F/FCd19Cre/+ B 
cells in the LPS-IL-4 data set identified the protein translation-related categories of 
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“Ribosome”, “Ribosome biogenesis in eukaryotes”, and “RNA transport” as the most 
significant categories (Fig. 4B). Furthermore, analysis of individual genes showed 
that the most significantly downregulated ones under both stimulations were factors 
essential for CSR and/or genes highly expressed or induced in activated B cells (e.g. 
Aicda, Batf, Ccl22, Ighg3, Tmem176b) (Fig. 4C and Table S1). In contrast, the top 
upregulated categories in both datasets were related to metabolic pathways of amino 
acid and aminoacyl-tRNA biosynthesis (Fig. 4B). Among the most significantly 
upregulated genes, we found key enzymes for the biosynthesis of asparagine (Asns), 
cysteine (Cth), and serine (Psat1, Psph), glutathione (GSH) metabolism (Chac1), 
amino acid transporters (Slc1a4, Slc6a9), and several other metabolic and 
cytoprotective genes (Fig. 4C, S5, and Table S1).  
 
These data indicate that, in addition to the inhibition of key factors of the CSR 
program, Pdap1 deficiency in activated B cells is accompanied by transcriptional 
changes that reflect initial repression of global protein synthesis, up-regulation of 
cellular stress response genes, and metabolic rewiring to aid translational recovery. 
These changes represent key aspects of the transcriptional program of the ISR (Ron 
and Walter, 2007; Pakos-Zebrucka et al., 2016). To confirm the activation of the ISR 
in Pdap1-deficient B cells, we monitored the kinetics of eIF2a phosphorylation and 
Atf4 expression in resting and in vitro-activated splenocytes. The eIF2a-Atf4 pathway 
is normally suppressed in splenic B cells, and is induced only at later time points after 
activation, when splenocyte cultures exhibit a general fitness decline (Fig. 4D, control 
cells, and (Zhu et al., 2019)). In contrast to control cells, resting B cells from 
Pdap1F/FCd19Cre/+ spleens displayed a marked phosphorylation of eIF2a and 
detectable levels of Atf4 protein, thus indicating a baseline activation of the ISR (Fig 
4D). Following activation, eIF2a phosphorylation was no longer detectable in both 
control and Pdap1-deficient cells (Fig. 4D). The autophosphorylation-dependent 
activation of the ER stress-activated eIF2a kinase PKR-like ER kinase (Perk) 
mirrored the phosphorylation profile of eIF2a (Fig. 4D). In contrast, Atf4 protein levels 
in Pdap1F/FCd19Cre/+ cells were more pronounced at 24 h after activation and 
increased steadily over time (Fig. 4D). We concluded that Pdap1 deficiency results in 
upregulation of the ISR core component Atf4. 
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Altogether, these data indicate that Pdap1 ablation in mature B cells induces Atf4-
dependent expression of stress response genes and downregulation of the CSR 
program. 
 
Pdap1 supports survival of mature B cells  
The ISR is an adaptive pathway meant to restore cellular homeostasis following cell 
intrinsic and extrinsic stresses (Harding et al., 2003, 2000; Brostrom et al., 1996; 
Dever et al., 1992; Ron and Walter, 2007; Pakos-Zebrucka et al., 2016; Harding et 
al., 1999). However, when the stress is severe in either intensity or duration and 
overwhelms the response adaptive capacity, the ISR activates the apoptotic cell 
death program (Pakos-Zebrucka et al., 2016). Furthermore, downregulation studies 
have implicated Pdap1 in cell survival and apoptosis resistance of cancer cell lines 
(Sharma et al., 2016; Weston et al., 2018).  Therefore, we tested whether activation 
of the stress response in the absence of Pdap1 would induce apoptosis in B cells. To 
do so, we monitored caspase activation in splenocytes by CaspGLOW staining. 
Caspase activity increased after stimulation and was higher in Pdap1-deficient cells 
compared to controls at 24 and 48 h post-activation (Fig. 5A). Accordingly, despite 
the unaffected proliferation capability (Fig. S2), the number of live cells in 
Pdap1F/FCd19Cre/+ splenocytes cultures was reduced 48 and 72 h after activation 
(Fig. 5B). Finally, we found that a large proportion of the Pdap1F/FCd19Cre/+ B cell 
cultures displayed reduced mitochondrial membrane potential at early time points 
after activation, which is indicative of increased mitochondrial membrane 
depolarization (Fig. 5C). 
 
Next, we tested whether Pdap1 deletion would affect the survival of activated B cells 
in vivo. To this end, we measured the percentage of GC B cells in Peyer's patches of 
Cd19Cre/+ and Pdap1F/FCd19Cre/+ mice. Peyer's patches are specialized secondary 
lymphoid tissues that line the wall of the small intestine. Because of their chronic 
exposure to an enormous variety of food- and microbiome-derived antigens, Peyer's 
patches display continual germinal center activity, and are key to the induction of 
mucosal IgA antibody responses (Reboldi and Cyster, 2016). We found that the 
percentage of GC B cells was reduced in Peyer's patches of Pdap1F/FCd19Cre/+ mice 
compared to the control group (Fig. 5D). In agreement with the CSR defect exhibited 
by Pdap1F/FCd19Cre/+ splenic B cells following activation in vitro (Fig. 2), the 
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percentage of switched IgA GC B cells was considerably decreased in 
Pdap1F/FCd19Cre/+ mice (Fig. 5D).  
 
Altogether, these data suggest that Pdap1 is required to support survival of activated 
B cells. 
 
Pdap1 is dispensable for plasma cell differentiation 
Plasma cell differentiation represents the terminal phase of B cell development, and 
is regulated by a transcriptional program that represses B cell identity while 
promoting the expression of plasma cell signature genes (Nutt et al., 2015; Shi et al., 
2015; Minnich et al., 2016). This process is accompanied by massive expansion of 
the ER and the upregulation of molecular chaperone and folding enzyme expression. 
The expansion of the secretory network is essential to accommodate the demands of 
increased immunoglobulin synthesis and secretion, and is dependent on the 
activation of the unfolded protein response (UPR) (Zhang et al., 2005; Gass et al., 
2002, 2008; Iwakoshi et al., 2003; Van Anken et al., 2003; Shaffer et al., 2004; 
Taubenheim et al., 2012; Todd et al., 2009). The UPR is a ubiquitous signaling 
network that senses and responds to the accumulation of misfolded proteins in the 
ER (Ron and Walter, 2007; Walter and Ron, 2011; Schroder and Kaufman, 2005). 
This response is mediated by three ER resident proteins, which in addition to Perk, 
comprise the inositol-requiring protein kinase/endoribonuclease-1 (Ire1) and the 
activating transcription factor 6 (Atf6) (Tirasophon et al., 1998; Wang et al., 1998; 
Haze et al., 1999, 2001). The UPR ultimately re-establishes protein homeostasis by 
integrating Perk-eIF2a-dependent attenuation of global protein synthesis with Ire1- 
and Atf6-mediated transcription of factors and enzymes that increase the protein 
folding and degradation capabilities of the ER.  
 
The Ire1 and Atf6 branches of the UPR are activated during normal differentiation of 
naïve B cells into plasma cells, and the Ire1 arm is essential for the expansion of their 
secretory network (Zhang et al., 2005; Gass et al., 2002; Iwakoshi et al., 2003; Van 
Anken et al., 2003; Gass et al., 2008; Aragon et al., 2012). In contrast, the Perk arm 
of the UPR is dispensable for plasma cell development (Zhang et al., 2005; Gass et 
al., 2008). Furthermore, this pathway is suppressed during differentiation of naïve B 
cells into plasma cells (Ma et al., 2010; Gass et al., 2008; Zhang et al., 2005), and 
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unrestricted Perk-eIF2a-Atf4 signaling in activated B cells blocks the formation of 
plasma cells (Zhu et al., 2019). Given the upregulated expression of Atf4 in Pdap1-
deficient B cells, we considered the possibility that plasma cell development might be 
impaired in the absence of Pdap1. To this end, we analyzed the plasma cell 
compartment of Pdap1F/FCd19Cre/+ mice. We found that the percentage and number 
of plasma cells (CD138+TACI+) in bone marrow and spleen of unimmunized mice 
was similar between control and Pdap1F/FCd19Cre/+ mice (Fig. 6A). 
 
Activation of naïve B cells with specific combinations of stimuli in vitro induces 
differentiation into plasmablasts. Plasmablasts are proliferating antibody-secreting 
cells whose differentiation is driven by the same transcriptional program responsible 
for plasma cell development (Nutt et al., 2015). Therefore, we tested the formation of 
plasmablasts (B220+CD138+) in vitro under the same stimulation conditions 
employed for our previous analyses. We observed no significant difference in the 
percentage of plasmablasts between controls and Pdap1F/FCd19Cre/+ cultures (Fig. 
6B). Accordingly, we did not detect any apparent change in the activation of the 
plasmablast and plasma cell gene signature between the two genotypes in the RNA-
Seq analysis (Table S1). We concluded that Atf4 upregulation in activated 
Pdap1F/FCd19Cre/+ B cells does not inhibit the generation of plasmablasts and plasma 
cells, and that Pdap1 is not required for the B cell developmental program controlling 
plasmablast and plasma cell formation and identity.  
 
The ER expansion and increase in protein processing and folding capabilities of 
plasma cells are regulated by the transcription factor Xbp1-s (spliced Xbp1) (Shaffer 
et al., 2004). Xbp1-deficiency in B cells does not interfere with the development of 
plasma cells, but impairs immunoglobulin secretion because of defective expansion 
of the secretory pathway (Hu et al., 2009; Todd et al., 2009; Taubenheim et al., 2012; 
Shaffer et al., 2004). Xbp1-s is expressed as a result of an unconventional splicing 
event mediated by Ire1 that removes a 26 nt segment from Xbp1 mRNA (unspliced 
Xbp1 transcript, Xbp1-u), thus changing the transcript reading frame in the resulting 
spliced Xbp1 transcript (Xbp1-s) (Fig. 6C and (Yoshida et al., 2001)). Xbp1-s 
translocates into the nucleus and activates the transcription of genes responsible for 
the expansion of the secretory pathway (Shaffer et al., 2004; Tellier et al., 2016). We 
found no difference in Xbp1 mRNA splicing and Xbp1-s expression levels between 
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control and Pdap1F/FCd19Cre/+ splenocytes cultures (Fig. 6, C and D). These results 
suggest that the transcriptional program controlling ER network expansion in plasma 
cells is not affected by Pdap1 deletion. 
 
We concluded that Pdap1 is dispensable for the differentiation programs that 
establish plasma cell identity and function.  
 
Pdap1 is required for efficient SHM of Ig loci 
Aicda is an haploinsufficient gene, and Aicda+/- mice exhibit defects in both antibody 
diversification reactions initiated by AID, CSR and SHM (McBride et al., 2008; 
Sernández et al., 2008; Takizawa et al., 2008). Given the reduced levels of AID 
expressed by Pdap1F/FCd19Cre/+ B cells following activation, we considered the 
possibility that Pdap1 depletion might affect also SHM. To test this hypothesis, we 
sequenced the intronic regions downstream of the JH4 and JK5 elements in GC B 
cells sorted from Peyer’s patches of aged Pdap1F/FCd19Cre/+ mice (Jolly et al., 1997). 
Because of their chronic exposure to microbial antigens, GC B cells in Peyer’s 
patches accumulate a high number of mutations over time (González-Fernández et 
al., 1994). Accordingly, we found that GC B cells from control mice displayed a high 
mutation frequency at both JH4 and JK5 intronic regions (Fig. 7, A to D). The vast 
majority of sequences contained mutations (86%, 79/92 for JH4, and 83%, 104/125 
for JK5), and a considerable portion of B cells was heavily mutated (Fig. 7, E and F). 
In contrast, Pdap1F/FCd19Cre/+ GC B cells exhibited a significantly lower mutation 
frequency at both JH4 and JK5 introns (Fig. 7, A to D). The distribution of mutations 
per sequence was skewed towards an increase in the proportion of sequences 
bearing no or less than 5 mutations (50%, 54/107 for JH4, and 65%, 83/127 for JK5), 
whereas the number of highly mutated clones was concomitantly reduced (Fig. 7, E 
and F). In agreement with a role of Pdap1 in promoting AID expression rather than 
the processing of AID-induced lesions, the profile of mutations was not affected by 
Pdap1 deletion (Fig. 7, G and H).  
 
Altogether, these findings indicate that ablation of Pdap1 impairs the efficiency of 
SHM of heavy and light chain Ig loci. Therefore, Pdap1 is required to support both 
antibody diversification reactions occurring in mature B cells, namely CSR and SHM.  
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In this study, we report the identification of a novel factor required for mature B cell 
homeostasis and function. Pdap1-deficient B cells develop normally, but display 
reduced cell viability at the mature stage both in vitro and in vivo. Furthermore, they 
fail to efficiently induce AID expression, and cannot support physiological levels of 
CSR and SHM. 
 
Pdap1 deficiency in mature B cells phenocopies key aspects of the cellular response 
to chronic stress. Stress-induced eIF2a phosphorylation drives the inhibition of global 
protein synthesis, while allowing the preferential translation of stress responsive 
genes like Atf4 (Harding et al., 2000; Hinnebusch, 2000; Scheuner et al., 2001; Lu et 
al., 2004). The transcriptional program induced by Atf4 comprises cytoprotective 
genes as well as the upregulation of biosynthetic pathways to reprogram cellular 
metabolism and aid homeostasis recovery. This anabolic program encompasses 
metabolic pathways of amino acid biosynthesis and the expression of amino acid 
transporter and aminoacyl-tRNA synthetases genes, and supports recovery of 
translation under conditions of acute stress (Harding et al., 2003; Rendleman et al., 
2018; Quirós et al., 2017; Krokowski et al., 2013; Han et al., 2013). However, during 
chronic stress, Atf4-dependent increase in protein synthesis leads to proteotoxicity, 
oxidative stress and cell death (Han et al., 2013; Krokowski et al., 2013). Pdap1-
deficient B cells express Atf4 and exhibit the same transcriptional signature of Atf4-
mediated translational recovery (Fig. 4, S5, and Table S1). Furthermore, the 
expression of this anabolic program correlates with increased apoptosis of 
Pdap1F/FCd19Cre/+ B cells. Therefore, our data is consistent with a model in which 
ablation of Pdap1 in activated B cells leads to cell death via induction of an Atf4-
dependent chronic stress response. In addition, resting B cells from Pdap1-deficient 
mice displayed phosphorylation of Perk and its downstream target eIF2a as well as 
Atf4 expression, thus indicating constitutive activation of the Perk-mediated ISR 
pathway. This result is in agreement with the reduced number of resting B cells 
isolated from spleens of Pdap1F/FCd19Cre/+ (Fig. S1E), and indicates that Pdap1-
deficiency is detrimental also in naïve B cells. Therefore, Pdap1 is required to protect 
B lymphocytes from stress-induced cell death under both resting and activated 
conditions.  
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Interestingly, while Atf4 expression increased steadily over time after activation in 
Pdap1-deficient B cells, phosphorylation of Perk and eIF2a was no longer detectable. 
This observation has two important implications. First, the upregulation of Atf4 
expression in Pdap1-ablated cells is uncoupled from Perk-eIF2a phosphorylation 
following activation. This result is in agreement with the identification of a phospho-
eIF2a-independent regulation of Atf4 expression observed during conditions of 
prolonged cellular stress (Guan et al., 2014). This regulation is likely under the 
control of mTORC1, which is activated in B cells after stimulation (Powell et al., 2012; 
Limon and Fruman, 2012; Iwata et al., 2017), and has been shown to promote Atf4 
translation in a phospho-eIF2a-independent manner in other cellular contexts (Park 
et al., 2017; Ben-Sahra et al., 2016). Second, the dephosphorylation of Perk and 
eIF2a occurs at early time points after activation. This observation implies the 
existence of an active mechanism operating immediately upon B cell activation that 
physiologically inhibits the Perk-eIF2a signaling cascade. In line with this point, 
although mature B cells retain the potential to activate all three arms of the UPR in 
response to pharmacological triggers of the pathway, the Perk branch is suppressed 
during normal differentiation of activated B cells into plasma cells (Ma et al., 2010; 
Gass et al., 2008; Zhang et al., 2005). It is interesting to notice that non-physiological 
Perk-eIF2a-Atf4 signaling after B cell activation blocks the formation of plasma cells 
(Zhu et al., 2019). In Pdap1F/FCd19Cre/+ splenocytes, the Perk-eIF2a-Atf4 pathway is 
already active under resting conditions, and the increased loss of mitochondrial 
membrane potential and apoptosis were observed at early, but not late, stages after 
activation. The earlier kinetics of Atf4 induction in our experimental conditions would 
explain why Pdap1-deficiency leads to cell death of naïve and early activated B cells 
but it does not affect the plasma cell compartment. 
 
The activation of the Atf4-dependent stress response in Pdap1F/FCd19Cre/+ B cells 
was accompanied by downregulation of key factors driving antibody diversification, 
including AID (Muramatsu et al., 2000; Revy et al., 2000) and the transcription factor 
Batf, which has been shown to directly control AID expression and other aspects of 
the CSR program (Ise et al., 2011). Defective induction of Aicda transcription in 
activated Pdap1-deficient B cells was common to all stimulation conditions (Fig. 3A 
and 4C), and likely represents the dominant cause for the reduced CSR and SHM 
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efficiency. Aicda is an haploinsufficient gene, and the efficiency of CSR is directly 
proportional to AID levels. Mice heterozygous for a null Aicda allele display defects in 
both CSR and SHM (McBride et al., 2008; Sernández et al., 2008; Takizawa et al., 
2008). Analogously, Pdap1 deficiency reduced Aicda expression to approximately 
half of wild-type levels in activated B cells, and is associated with a similar reduction 
in the efficiency of both antibody diversification reactions. Furthermore, 
overexpression of AID in LPS-BAFF-TGFb-stimulated splenocytes, which did not 
exhibit any additional defect in GLT, rescued the IgG2b CSR defect of 
Pdap1F/FCd19Cre/+ B cells to a considerable extent. Although we cannot exclude the 
possibility that Pdap1 might regulate the expression of AID independently from its 
protective role against chronic ISR activation, it is intriguing to speculate that the 
sustained induction of the ISR in Pdap1F/FCd19Cre/+ B cells might actively interfere 
with the CSR and SHM programs. In this regard, limiting AID expression under 
conditions of cellular stress might represent a mechanism to alleviate the additional 
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Figure 1. Loss of Pdap1 in CH12 cells impairs CSR. A. Scheme of murine Pdap1 
genomic locus and location of gRNAs used for gene targeting (scheme adapted from 
Ensembl Pdap1-201 ENSMUST00000031627.8). B. Top left: Representative flow 
cytometry plots measuring CSR to IgA in activated Cas9/gPdap1-nucleofected CH12 
cells. Numbers in the plots refer to the percentage of switched cells (= IgA+ cells). 
Top right: Summary graph for three independent experiments employing gPdap1-1/3 
(individually / in pooled format) or Nickases-a/c (individually). Controls for gRNA-
nucleofected CH12 were cells nucleofected either with empty vector or gRNAs 
against random sequences not present in the mouse genome (gCtrl). A previously 
described gRNA against the CSR factor 53BP1 (Delgado-Benito et al., 2018) was 
used as a positive control for loss-of-CSR function. Bottom: Western blot analysis of 
whole cell extracts from CH12 cultures nucleofected with Nickases-a to -c. Triangles 
indicate twofold dilution. Asterisk denotes aspecific bands used for internal 
normalization of protein levels. N: Nickase. C. Graph summarizing CSR efficiency of 
activated CH12 clonal cell lines derived by nucleofection of CH12 cultures with 
Nickases-a/c and single cell sorting. Each symbol in the graphs indicates a single cell 
clonal derivative. D. Left: Genomic scars of the targeted alleles in the selected 
Pdap1-deficient CH12 clonal derivatives. fs: frameshift; PTC: premature termination 
codon; D: bp deletion; het: heterozygous configuration (different indels causing fs and 
PTC at the two Pdap1 alleles); homo: homozygous configuration. Right: 
Representative WB analysis of WT and Pdap1-deficient CH12 cell lines. R1 and R2 
are WT clonal derivatives generated by targeting CH12 with random sequences not 
present in the mouse genome. mut: mutated. Asterisk denotes aspecific bands. E. 
Left: Representative flow cytometry plots measuring CSR to IgA in activated CH12 
cell lines of the indicated genotypes. WT controls included both the parental CH12 
cell line (WT) and the random clonal derivatives R1 and R2. Right: Summary graph 
for four independent experiments. Significance in panels B, C and E was calculated 
with the Mann–Whitney U test, and error bars represent SD. * = p ≤ 0.05; ** = p ≤ 
0.01; *** = p ≤ 0.001. 
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Figure 2. Pdap1 promotes CSR in primary B cells. A-D. Left: Representative flow 
cytometry plots measuring CSR to IgG1 (A), IgG3 (B), IgG2b (C), and IgA (D) in 
splenocytes activated with LPS and IL-4 (A), LPS (B), LPS, BAFF, and TGFb (C), or 
LPS, BAFF, TGFb, and IL-5 (D). Numbers in the plots refer to the percentage of 
switched cells (= IgG1+/IgG3+/IgG2b+/IgGA+ cells). Right: Summary graph for at least 
6 mice per time point per genotype. E. Western blot analysis of whole cell extracts 
from B cells of the indicated genotypes 96 h after stimulation with LPS and IL-4 (left) 
or LPS, BAFF, and TGFb (right). Numbers 1 and 2 indicate two different 
Pdap1F/FCd19Cre/+ mice. Triangles indicate threefold dilution. Asterisk denotes 
aspecific bands. Significance in panels A to D was calculated with the Mann–Whitney 
U test, and error bars represent SD. * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 0.001; **** = 
p ≤ 0.0001. See also Figures S1 and S2.  
 
Figure 3. Pdap1 supports physiological levels of AID expression. A-C. qPCR 
analysis for Aicda mRNA (A), Igµ (B), and Igg1 / Igg3 / Igg2b / Iga (C) GLT levels in B 
cells activated to undergo CSR to the corresponding isotypes. The schematic 
representations on the left in panels B and C indicate the location of primers 
employed to analyze the germline transcripts. Graphs summarize 4 to 8 mice per 
genotype per stimulation condition. One control mouse (Cd19Cre/+ or Pdap1F/F) within 
each experiment was assigned an arbitrary value of 1. D. Representative WB 
analysis of splenocytes of the indicated genotypes 48 h after stimulation with LPS 
and IL-4. Numbers 1 and 2 indicate two different mice per genotype. Triangles 
indicate threefold dilution. Asterisk denotes aspecific bands. E. Summary graphs 
showing CSR to IgG2b (top) and IgG1 (bottom) following transduction of splenocytes 
of the indicated genotypes with either empty vector (EV) or an AID-ER-expressing 
retroviral construct. 4-HT: 4-hydroxytamoxifen. Graphs summarize 3-8 mice per 
genotype analysed in three (IgG2b) or four (IgG1) independent experiments. 
Significance in panels A, C and E was calculated with the Mann–Whitney U test. 
Error bars represent SD. ns: not significant; * = p ≤ 0.05; ** = p ≤ 0.01; *** = p ≤ 
0.001. See also Figures S3 and S4. 
 
Figure 4. Pdap1-deficient B cells activate the Atf4 stress response 
transcriptional program. A. Scatterplots of gene expression in Pdap1F/FCd19Cre/+ 
versus control (Cd19Cre/+) mature B cells stimulated with LPS and IL-4 (top) or LPS, 
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BAFF, and TGFb (bottom). Genes with an adjusted p-value (FDR) < 0.05 that are up- 
or downregulated in Pdap1F/FCd19Cre/+ cells are highlighted in red or purple, 
respectively. Data summarizes results from 3 mice per genotype per stimulation 
condition, and is presented as log2(RPM) (reads per gene per million mapped 
sequence reads) values. B. Pathway enrichment analysis (KEGG pathways) of the 
differentially regulated genes (FDR < 0.05) from panel A. The number of differentially 
regulated genes in each category is indicated. C. Volcano plots displaying 
differentially expressed genes between control and Pdap1-deficient splenocytes 
activated with LPS and IL-4 (right) or LPS, BAFF, and TGFb (left). The red and 
purple dots represent transcripts up- and downregulated in Pdap1F/FCd19Cre/+ cells, 
respectively, with FDR < 0.05 and expression fold change > 2 (upregulated) or 1.7 
(downregulated) in both stimulation conditions. The names of the downregulated and 
the 30 most significantly upregulated genes within each stimulation condition are 
indicated in each graph. The fold change threshold for downregulated genes was set 
to 1.7 to include genes yielding a biologically relevant effect even with less 
pronounced variations in expression levels (e.g. Aicda, haploinsufficient gene). D. 
Representative WB analysis of splenocytes of the indicated genotypes before 
(resting B cells) and after 24 to 96 h activation with LPS and IL-4. Data is 
representative of 2 mice per genotype. See also Figure S5 and Table S1. 
 
Figure 5. Pdap1 supports survival of mature B cells. A. Top: Representative flow 
cytometry plots measuring percentage of active caspases+ cells in resting and 
activated (LPS-IL-4, or LPS-BAFF-TGFb, 24 to 72 h) splenocytes of the indicated 
genotypes. Bottom: Summary graph for 4 mice per genotype. B. Live cell count of 
splenocytes of the indicated genotypes activated with LPS and IL-4. Resting B cells 
were counted and seeded at same density on day 0. Data summarizes three 
independent experiments for a total of 6 mice per genotype, and is normalized within 
each experiment to the average of live cell count for control cultures at 48 h, which 
was set to 1. C. Left: Representative flow cytometry plots measuring mitochondrial 
membrane potential (MMP) and mass by MitoTracker deep red and green staining, 
respectively, in splenocyte cultures of the indicated genotype 24, 48, and 72 h after 
activation with LPS and IL-4. Right: Summary graph for 7 mice per genotype. D. Left: 
Representative flow cytometry plots measuring percentage of germinal center (GC) B 
cells and IgA+ GC cells in Peyer's patches (PP) of unimmunized mice. Right: 
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Summary graphs for at least 5 mice per genotype. Significance in panels A, B, C, 
and D was calculated with the Mann–Whitney U test, and error bars represent SD. * 
= p ≤ 0.05; ** = p ≤ 0.01. 
 
Figure 6. Pdap1 is dispensable for plasma cell differentiation. A. Left: 
Representative flow cytometry plots showing percentage of plasma cells 
(CD138+TACI+) in bone marrow (BM) and spleen (SPL) of unimmunized mice of the 
indicated genotypes and age. Right: Summary graphs showing percentage and 
number of plasma cells for 3 mice per genotype and age group. B. Top: 
Representative flow cytometry plots measuring percentage of plasmablasts 
(B220intCD138+) in splenocyte cultures of the indicated genotypes 96 h after 
activation with LPS and IL-4, or LPS, BAFF, and TGFb. Bottom: Summary graph for 
6 mice per genotype. C. Top: Schematic representation of Xbp1 mRNA RT-PCR and 
digestion products. Bottom: Electrophoretic analysis of Xbp1 splicing in splenocytes 
cultures of the indicated genotypes 48 h after activation with LPS and IL-4. The DNA 
bands of 447 bp for the intact spliced (Xbp1-s) transcript RT-PCR product, and the 
unspliced (Xbp1-u) transcript digestion products of 290 bp and 183 bp are indicated. 
Results for 3 mice per genotype are shown. D. Representative WB analysis of 
splenocytes of the indicated genotypes 72 h after activation with LPS and IL-4. 
Resting B cells from a WT control mouse (Ctrl) were analysed in parallel to show the 
expected undetectable levels of Xbp1-s before activation. Numbers 1 and 2 indicate 
two different mice per genotype. No difference among groups was significant for 
graphs in panels A and B (Mann–Whitney U test).  
 
Figure 7. Pdap1 is required for efficient SHM of Ig loci. A and B. Graphs 
summarizing number of mutations in 3’ JH4 (A) and 3’ Jk5 (B) regions cloned from 
sorted Peyer’s patches B cells of aged, unimmunized mice (5 mice per genotype). 
Each symbol in the graphs indicates a single sequence, and the total number of 
sequences analysed for each group is indicated below. Mutations were quantified 
over 510 bp downstream JH4 gene segment (A) and 536 bp downstream JK5 gene 
segment (B). NGC: non-germinal center; GC: germinal center. C and D. Summary 
tables listing number of analyzed sequences and total length, number of mutations, 
and mutation frequency at JH4 (C) and JK5 (D) introns from panels A and B. E and F. 
Graphs showing the percentage of sequences from panels A and B bearing the 
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indicated mutations in 3’ JH4 (E) and 3’ Jk5 (F). G and H. Profiles of nucleotide 
substitutions at 3’ JH4 (G) and 3’ Jk5 (H) regions. Significance in panels A and B was 
calculated with the Mann–Whitney U test, and the median is indicated. ** = p ≤ 0.01; 
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Supplementary Figure Legends 
 
 
Figure S1. Pdap1 is largely dispensable for B cell development. A. Schematic 
representation of Pdap1 locus and genotyping strategy. WT: wildtype Pdap1 allele; 
Flox: conditional Pdap1 allele; D: null Pdap1 allele. B. Electrophoretic analysis of 
Pdap1 allele status in resting splenic B cells isolated from mice of the indicated 
genotype. C. Representative flow cytometry analysis of lymphoid tissues from control 
and Pdap1F/FCd19Cre/+ mice. D. Summary graphs for 4 mice per genotype. E. Number 
of resting B cells isolated from spleens of the indicated genotype. Each dot 
represents a different mouse. Significance in panels D and E was calculated with the 
Mann–Whitney U test, and error bars represent SD. No difference among groups 
was significant for graphs in panel D. **** = p ≤ 0.0001.  
 
Figure S2. Pdap1 is dispensable for B cell proliferation. A-D. Proliferation 
analysis by CellTrace Violet dilution of primary cultures of Cd19Cre/+ and 
Pdap1F/FCd19Cre/+ B lymphocytes stimulated with LPS-IL-4 (A), LPS only (B), LPS-
BAFF-TGFb (C), or LPS-BAFF-TGFb-IL-5 (D). Data are representative of at least 2 
mice per genotype. E. Graph showing percentage of IgG1+ cells per cell division in 
primary cultures of Cd19Cre/+ and Pdap1F/FCd19Cre/+ splenocytes stimulated with LPS 
and IL-4 for 72 h. Graph summarizes at least 3 mice per genotype, and error bars 
represent SD. Representative cell division plots as measured by CellTrace Violet 
dilution are shown on top. F. Representative overlay of CellTrace Violet proliferation 
tracks of LPS-IL-4 and LPS-BAFF-TGFb cultures at 48 h post-activation.  
 
Figure S3. Aicda mRNA levels are reduced in Pdap1-deficient CH12 cell lines. 
A. qPCR analysis for Aicda mRNA in activated CH12 cell lines of the indicated 
genotypes. Graph summarizes four independent experiments. Parental WT CH12 
cells within each experiment were assigned an arbitrary value of 1. B and C. qPCR 
analysis for Igµ (B) and Iga (C) GLT levels in activated CH12 cell lines of the 
indicated genotypes. The schematic representations on top of each graph indicate 
the location of primers employed to analyze post-spliced germline transcripts. Graphs 
summarize four independent experiments. Parental WT CH12 cells within each 
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experiment were assigned an arbitrary value of 1. Significance in panel A was 
calculated with the Mann–Whitney U test. Error bars represent SD. * = p ≤ 0.05.  
 
Figure S4. Pdap1 is dispensable for Aicda mRNA stability and splicing. A-B. 
Left: qPCR analysis for Aicda mRNA from B cells of the indicated genotypes 
stimulated with LPS and IL-4 (A) or LPS, BAFF and TGFb (B) for 48 h to induce CSR 
to IgG1 or IgG2b, respectively, and treated with Actinomycin-D for the indicated time. 
Graph summarizes the mean of two independent qPCR measurements per mouse 
for 2 mice per genotype. Right: Linear regression analysis of same data, shown as 
ln[RNA] versus time of Actinomycin-D treatment. C. Analysis of exon usage for Aicda 
(left) and Pdap1 (right) genes. Pdap1 splicing data is provided as a positive control 
for the spicing analysis. A schematic representation of each gene is provided above. 
D. Left: Schematic representation of Aicda gene with location of primers employed to 
analyze Aicda primary and spliced transcripts. Right: qPCR analysis of Aicda primary 
transcripts in B cells 48 h after activation with LPS. Graphs summarize at least 4 
mice per genotype. Results of qPCR analysis of Aicda spliced transcripts are shown 
in Fig. 3A. One Cd19Cre/+ mouse within each experiment was assigned an arbitrary 
value of 1. Significance in panel D was calculated with the Mann–Whitney U test, and 
error bars represent SD. * = p ≤ 0.05.   
 
Figure S5. Increased expression of stress response genes in Pdap1-deficient B 
cells. Coverage of stress response genes in B cells of the indicated genotypes 48 h 
after activation with LPS and IL-4 (L-I4) or LPS, BAFF, and TGFb (L-B-Tb), as 
measured by RNA-Seq analysis. Twelve selected genes are shown.  
 
Table S1. Pairwise comparison of differentially regulated genes in control 
versus Pdap1F/FCd19Cre/+ splenocytes. 
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Cd19Cre (Cd19tm1(cre)Cgn, (Rickert et al., 1997)) and  Aicda-/- (Aicdatm1Hon/tm1Hon, 
(Muramatsu et al., 2000)) mice were previously described. The conditional Pdap1F 
allele bears LoxP sites flanking Exon 2 (ENSMUST00000031627.8), and was 
generated by CRISPR/Cas9-mediated knock-in microinjection of single cell embryos 
on a C57BL/6N strain background (MDC Transgenics platform). Germline 
transmission was confirmed and positive pups were bred with Cd19Cre mice to 
generate Pdap1F/FCd19Cre/+ mice. Mice were maintained in a specific pathogen-
free (SPF) barrier facility under standardized conditions (20+/-2 °C temperature; 
55%±15% humidity) on a 12 h light/12 h dark cycle. Mice of both genders 7 to 27 
weeks old were used in age-matched groups for the experiments. All experiments 
were performed in compliance with the European Union (EU) directive 2010/63/EU, 
and in agreement with Landesamt für Gesundheit und Soziales directives (LAGeSo, 
Berlin, Germany). Primers used for genotyping the Pdap1F allele are listed in Table 
S2.  
 
Primary cell cultures 
B lymphocytes were isolated from mouse spleens using anti-CD43 MicroBeads 
(Miltenyi Biotec), and grown in RPMI 1640 medium (Life Technologies) 
supplemented with 10% fetal bovine serum (FBS), 10 mM HEPES (Life 
Technologies), 1 mM Sodium Pyruvate (Life Technologies), 1X Antibiotic Antimycotic 
(Life Technologies), 2 mM L-Glutamine (Life Technologies), and 1X 2-
Mercaptoethanol (Life Technologies) at 37 °C and 5% CO2 levels.  
 
Cell lines 
The cell lines employed for this study are: CH12 (CH12F3, murine, (Nakamura et al., 
1996)), WT (R1 and R2) and Pdap1-deficient (P1, P2, and P3) CH12 clonal 
derivatives (murine, this paper), and BOSC23 (human, (Pear et al., 1993)). CH12 
cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum 
(FBS), 10 mM HEPES, 1 mM Sodium Pyruvate, 1X Antibiotic Antimycotic, 2 mM L-
Glutamine, and 1X 2-Mercaptoethanol at 37 °C and 5% CO2 levels. BOSC23 cells 
were cultured in DMEM medium (Life Technologies) supplemented with 10% FBS, 2 
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mM L-Glutamine, and Penicillin-Streptomycin (Life Technologies) at 37 °C and 
5% CO2 levels.  
 
CSR assay 
CH12 cells were stimulated to undergo CSR to IgA by treatment with 1-5 µg/mL 
aCD40 (BioLegend), 5 ng/ml TGFb (R&D Systems) and 5 ng/ml of mouse 
recombinant IL-4 for 48 h. B lymphocytes were stimulated to undergo class switching 
with 5 µg/ml LPS (Sigma-Aldrich) and 5 ng/ml of mouse recombinant IL-4 (Sigma-
Aldrich) for CSR to IgG1; 5 µg/ml LPS only for CSR to IgG3; 5 µg/ml LPS, 10 
ng/ml BAFF (PeproTech) and 2 ng/ml TGFb for CSR to IgG2b; or 5 µg/ml LPS, 10 
ng/ml BAFF, 2 ng/ml TGFb and 1.5 ng/ml recombinant murine IL-5 (PeproTech) for 
CSR to IgA. For class switching analysis, cell suspensions were stained with 
fluorochrome-conjugated anti-IgG1, anti-IgG3 (BD-Biosciences), anti-IgG2b 
(BioLegend), or anti-IgA (Southern Biotech).  
 
Retroviral infection 
The pMX-AID-ER-IRES-GFP retroviral vector was a kind gift from Qiao Wang (The 
Rockefeller University, New York). Splenocytes infections were performed as it 
follows. The 293T derivative cell line BOSC23 was transfected with pCL-Eco and 
pMX-IRES-GFP or pMX-AID-ER-IRES-GFP retroviral vectors using FuGENE® HD 
Transfection Reagent (Promega) to generate viral particle-containing supernatants. 
B-cells were activated with 5 µg/ml LPS and 5 ng/ml IL-4 (IgG1) or 5 µg/ml LPS, 10 
ng/ml BAFF and 2 ng/ml TGFb  (IgG2b), and transduced twice with the viral 
supernatant, one and two days after isolation. 4-hydroxytamoxifen (4-HT) was added 
72 h post-activation at a final concentration of 0.05 µM, and CSR was assessed 24 h 
after on the GFP+-gated populations. 
 
B cell development and differentiation analyses 
For analysis of B cell development and differentiation, spleen and bone marrow cell 
suspensions were incubated with ACK lysis buffer (ThermoFisher) for erythrocytes 
depletion. Subsequently, cells were blocked with TruStain fcX (BioLegend) for 10 min 
at 4 °C and labeled with fluorochrome conjugated antibodies to determine the surface 
expression of CD43, IgM, CD21/CD35, IgD (BD Biosciences) and CD23, CD3 and 
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CD19 (BioLegend) in PBS supplemented with 3 % FBS (PBS/FBS) for 20 min at 4 
°C. Cells were then washed, resuspended in PBS/FBS and analyzed.  
For analysis of plasma cell differentiation in vitro, splenic B cells were isolated by 
immunomagnetic depletion of CD43+ cells, and cultured at a density of 106 cells/ml in 
the presence of either 20 µg/ml LPS (Sigma, #L2880-10MG) and 25 ng/ml IL-4, or 
20 µg/ml LPS, 10 ng/ml BAFF, and 2 ng/ml TGFb. To determine the percentage of 
plasmablasts, cells were harvested after 96 hours, blocked with TruStain fcX for 10 
min at 4 °C, and subsequently stained for surface expression of B220 (BioLegend, 
#103245) and CD138 (BioLegend, #142506) in MACS buffer (PBS supplemented 
with 0.5 % BSA and 2 mM EDTA) for 20 min at 4 °C. Cells were then resuspended in 
FACS buffer (PBS supplemented with 3 % FCS and 1 mM EDTA) containing 1 µg/ml 
propidium iodide and analyzed. 
For analysis of the plasma cell compartment in vivo, 9, 14 and 25 weeks old mice 
were sacrificed to isolate the spleen and hind legs. Total splenocytes and bone 
marrow cells were isolated by smashing the respective organs and erythrocytes were 
depleted by incubation with Gey’s ABC solution for 3 min on ice. For surface staining, 
5x106 cells were first blocked with TruStain fcX for 10 min at 4 °C and then stained 
for the following markers for 20 min at 4 °C in MACS buffer: CD138, TACI (BD 
Pharmingen, #558410), CD93 (BioLegend, #136506), CD19 (BioLegend) and B220. 
Cells were resuspended in FACS buffer containing 1 µg/mL propidium iodide and 
analyzed. 
For assessment of germinal center B cells and CSR in vivo, cell suspensions derived 
from Peyer’s Patches were blocked with TruStain fcX for 10 min at 4 °C. 
Subsequently, cells were stained with fluorochrome-conjugated anti-CD19, anti-
B220/CD45R, anti-CD38 (BioLegend) anti-Fas/CD95 and anti-IgA (BD Biosciences) 
for 20 min at 4 °C in PBS/FBS. Cells were washed, resuspended in PBS/FBS and 
analyzed. 
All samples were acquired on a LSRFortessa cell analyzer (BD-Biosciences). 
 
Cell proliferation and apoptosis analysis 
For cell proliferation analysis by cell tracking dye dilution, primary B cells were pulsed 
with 5 µM CellTrace Violet (Thermofisher) for 10 min at 37 °C. Apoptosis analysis 
was performed by using CaspGLOW™ Fluorescein Active Caspase Staining Kit 
(BioVision) according to the manufacturer's instructions. Samples were acquired on a 
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LSRFortessa cell analyzer (BD-Biosciences). Mitochondrial mass and membrane 
potential were measured via staining with MitoTracker Green and DeepRed 
(ThermoFisher), respectively, according to the manufacturer's instructions. Samples 
were acquired on a LSRFortessa cell analyzer (BD-Biosciences).  
 
CRISPR-Cas9 gene targeting 
For the loss-of-CSR assay in bulk CH12 cultures, 3 gRNAs against Pdap1 gene were 
cloned into the U6 cassette of a variant of the original pX330 plasmid (pX330-U6-
Chimeric_BB-CBh-hSpCas9, Addgene #42230) modified to express Cas9WT-T2A-
GFP (kind gift from Van Trung Chu, MDC) (gPdap1-1/3), and 3 gRNA pairs were 
cloned into tandem U6 cassettes in a mutated version of pX330 expressing Cas9D10A 
(Nickase-a/c). CH12 cells were transfected with the Cas9-gRNAs expressing 
constructs (either individually or in a pooled format) via electroporation with Neon 
Transfection System (Thermo Fisher Scientific), sorted for GFP-positive cells after 40 
h, and left to recover for 72 h before activation for CSR analysis. For the generation 
of Pdap1-deficient CH12 clonal derivatives, the Nickases-a/c constructs were 
individually electroporated into CH12. Single GFP-positive cells were sorted in 96-
well plates after 40 h, and clones were allowed to grow for 12 days before CSR 
analysis in 96-well format and expansion of selected clones. Controls for gRNA-
nucleofected CH12 were cells nucleofected either with empty vector or gRNAs 
against random sequences not present in the mouse genome (single random gRNA-
Cas9WT as controls for gPdap1-1/3, and random gRNAs pairs-Cas9D10A as controls 
for Nickase-a/c). Selected clones R1/R2 and P1/3 were validated at the level of 
genomic scar and protein expression. The sequences of the gRNAs employed in 
these studies (this paper; (Delgado-Benito et al., 2018)) are listed in Table S2.  
 
Western blot analysis 
Western blot analysis of protein levels was performed on whole cell lysates prepared 
by lysis in RIPA buffer (Sigma) supplemented with Complete EDTA free proteinase 
inhibitors (Roche). Pierce Phosphatase Inhibitor Mini Tablets (ThermoFisher) were 
added to the lysis buffer for the analysis of phosphorylated Perk and eIF2a. The 
antibodies used for WB analysis are: anti-Pdap1 (Sigma), anti-Tubulin (Abcam), anti-
bActin (Sigma), anti-AID (mAID-2, ThermoFisher), anti-phospho-Perk (pThr980, 
ThermoFisher), anti-Perk (Cell Signaling Technology), anti-phospho-eIF2a (pSer51, 
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Cell Signaling Technology), anti-eIF2a (Santa Cruz), anti-Atf4 (Cell Signaling 
Technology), and anti-Xbp1-s (Cell Signaling Technology). 
 
RT- and quantitative PCR 
mRNA levels for AID and post-spliced germline transcripts were measured as it 
follows. Total RNA was extracted from splenocytes cultures 48 h after activation 
using TRIzol (Invitrogen) according to manufacturer's instructions, and retro-
transcribed with SuperScript VILO cDNA Synthesis Kit (Invitrogen). Genomic DNA 
was removed by RapidOut DNA Removal Kit (Thermo Scientific). Transcripts were 
amplified using StepOnePlus Real-Time PCR System (Applied Biosystems) with 
Luna Universal qPCR Mastermix (NEB). For analysis of Aicda mRNA decay, 
Actinomycin D was added to the culture medium 48 h post-activation at a final 
concentration of 10 µg/ml for 0.5, 1, 1.5, 2, 3, and 4 hr. qPCR analyses were 
normalized to Ubc or Gapdh (Aicda mRNA and GLTs) or Gapdh (Aicda mRNA 
decay). Primers used for qPCR (this paper; (Xu et al., 2015; Muramatsu et al., 2000; 
Albershardt et al., 2012)) are listed in Table S2.  
For electrophoretic analysis of Xbp1 splicing, Xbp1 transcripts were amplified using 
the primers listed in Table S2 (Madaro et al., 2013), and either mock-digested or 
digested with PstI enzyme (NEB) for 30 min at 37 °C. The intact spliced (Xbp1-s) 
transcript RT-PCR product and the unspliced (Xbp1-u) transcript digestion products 
were visualized on 2% agarose gel. 
 
RNA-Seq  
RNA-Seq analysis was performed on three mice per genotype. Splenocytes were 
cultured in LPS and IL-4 (IgG1) or LPS, BAFF and TGFb (IgG2b) for 48 h. Cells were 
collected by centrifugation and RNA was extracted with TRIzol (Invitrogen) according 
to manufacturer's instructions. Ribosomal RNA was depleted using Ribo-Zero Gold 
rRNA Removal Kit (Illumina). Libraries were prepared with TruSeq Stranded Total 
RNA Library Prep Kit Gold (Illumina), and run in one lane on a flow cell of HiSeq 
4000 (Illumina).  
The RNA-seq data was analysed using the pigx-rnaseq pipeline (Wurmus et al., 
2018). STAR (Dobin et al., 2013) mapped the reads to the GRCm38 assembly for 
mouse by Ensembl, and HTSeq (Anders et al., 2015) was used to count the 
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transcript abundance. Differential expression analysis was done using the DESeq2 
(Love et al., 2014) package for R, which uses the Wald test for significance. 
For splicing analysis of Aicda and Pdap1 genes, we used the edgeR (Robinson et al., 
2010) package for R to determine differentially expressed exons. The annotation was 
provided by a filtered version of the GRCm38 gene annotation, which contained 
unique, Havana annotated exons.  
 
SHM analysis 
Single-cell suspensions from Peyer’s patches of 24-27 weeks old mice were first 
incubated with TruStain fcX, and then labeled with B220-FITC- (BioLegend), CD19-
APC/Pacific Blue (BioLegend), CD38-Alexa700- (Thermo Scientific), and CD95/Fas-
PE- (BD-Biosciences) conjugated antibodies. Non-germinal center (CD38+ Fas-) and 
germinal center B cells (CD38- Fas+) were sorted on an Aria BD sorter. Genomic 
DNA was extracted and the 5’ portions of JH4 (Igh) and JK5 (Igk) introns were 
amplified by PCR using Phusion High-Fidelity DNA Polymerase (Thermo Scientific). 
The 800 bp JH4 and 700 bp JK5 PCR products were gel extracted, cloned into a 
pCR2.1 vector using the TOPO TA Cloning Kit (Invitrogen) and sequenced. 
Mutations were quantified over 510 bp downstream JH4 and 536 bp downstream JK5 
gene segments. Primers used for SHM analysis (Rouaud et al., 2013; Sander et al., 
2015) are listed in Table S2.   
 
Statistical analysis 
The statistical significance of differences between groups/datasets was determined 
by the Mann–Whitney U test for all data presented in this study, with the following 
exceptions. For the RNA-Seq analysis, the Wald test of the DESeq2 package for R 
was used, and we considered genes with an FDR < 0.05 to be significantly 
differentially expressed. Statistical details of experiments can be found in the figure 
legends. 
 
Data availability  
The deep-sequencing data reported in this paper (RNA-Seq) has been deposited in 
the GEO repository under accession number GSE141876. 
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n = 31 n = 30 n = 92 n = 107 n = 37 n = 39 n = 125 n = 127
Pdap1F/F Cd19Cre/+Pdap1F/F & Cd19Cre/+
N. seq. 92 107
Total bp 46,920 54,570
N. mut. 1,239 946
Mut/bp 0.026 0.017
Jk5 Pdap1F/F Cd19Cre/+Pdap1F/F & Cd19Cre/+
N. seq. 125 127
Total bp 67,000 68,072
N. mut. 1,544 842
Mut/bp 0.023 0.012
Pdap1F/F Cd19Cre/+Pdap1F/F & Cd19Cre/+ Pdap1F/F Cd19Cre/+Pdap1F/F & Cd19Cre/+
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Table S2. List of oligonucleotides used in this study. 
 
Pdap1F allele genotyping 
 
PCR primers Sequence (5’à3’) Reference 
MDV_p313 (Fw) GTCCTATGATTGGACCAAC This paper 
MDV_p226 (Rev) GGGAAGGCAGGCTGTATGTT This paper 
MDV_p223 (Fw) CTGGGGAAAAGGAGGCTCTG This paper 
 
 
CRISPR-Cas9 gene targeting 
 
gRNAs Sequence (5’à3’) Reference 
gPdap1-1 AGTGAGGCAGTATACGAGCC This paper 
gPdap1-2 CATTGAGAACCCCAACCGCG This paper 
gPdap1-3 ACTGGATCTGGACGGGCCAA This paper 
gPdap1-4 GAAGGTCACGCAACTGGATC This paper 
gPdap1-5 TTGTCTGTGCCACGCGGTTG This paper 
gPdap1-6 GTTGTCTGTGCCACGCGGTT This paper 
g53bp1 GAGTGTACGGACTTCTCGAA (Delgado-Benito et al., 2018) 
gRandom-1 GCGAGGTATTCGGCTCCGCG (Delgado-Benito et al., 2018) 
gRandom-2 ATGTTGCAGTTCGGCTCGAT (Delgado-Benito et al., 2018) 
gRandom-3 ACGTGTAAGGCGAACGCCTT This paper 
 
 
Quantitative pCR  
 
Aicda  Sequence (5’à3’) Reference 
AID-F (Fw) GAAAGTCACGCTGGAGACCG (Xu et al., 2015) 
AID-R (Rev) TCTCATGCCGTCCCTTGG (Xu et al., 2015) 
119-AID (Fw) GAGGGAGTCAAGAAAGTCACGCTGGA (Muramatsu et al., 2000) 
118-AID (Rev) GGCTGAGGTTAGGGTTCCATCTCAG (Muramatsu et al., 2000) 
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MDV_p504 (Rev) AGGGTGGCAAGCAGACGAGG This paper 
post-spliced GLTµ   
ImF (Fw) CTCTGGCCCTGCTTATTGTTG (Muramatsu et al., 2000) 
CmR (Rev) GAAGACATTTGGGAAGGACTGACT (Muramatsu et al., 2000) 
post-spliced GLTg1     
Ig1 (Fw) GGCCCTTCCAGATCTTTGAG (Muramatsu et al., 2000) 
Cg1R (Rev) GGATCCAGAGTTCCAGGTCACT (Muramatsu et al., 2000) 
post-spliced GLTg3    
Ig3F (Fw) TGGGCAAGTGGATCTGAACA (Muramatsu et al., 2000) 
Cg3R (Rev) CTCAGGGAAGTAGCCTTTGACA (Muramatsu et al., 2000) 
post-spliced GLTg2b    
MDV_p243 (Fw) CACTGGGCCTTTCCAGAACTA (Muramatsu et al., 2000) 
MDV_p244 (Rev) CACTGAGCTGCTCATAGTGTAGAGTC (Muramatsu et al., 2000) 
post-spliced GLTa   
IaF (Fw) CCTGGCTGTTCCCCTATGAA (Muramatsu et al., 2000) 
CaR (Rev) GAGCTGGTGGGAGTGTCAGTG (Muramatsu et al., 2000) 
Housekeeping   
Ubc_Fw GCCCAGTGTTACCACCAAGA (Albershardt et al., 2012) 
Ubc_Rev CCCATCACACCCAAGAACA (Albershardt et al., 2012) 
Gapdh_Fw TGTGTCCGTCGTGGATCTGA 
(Albershardt et al., 
2012) 
 
Gapdh_Rev TTGCTGTTGAAGTCGCAGGAG (Albershardt et al., 2012) 
 
 
Electrophoretic analysis of Xbp1 splicing 
 
PCR primers Sequence (5’à3’) Reference 
Xbp1_Fw  AAACAGAGTAGCAGCGCAGACTGC (Madaro et al., 2013) 
Xbp1_Rev TCCTTCTGGGTAGACCTCTGGGAG (Madaro et al., 2013) 
 
 
SHM analysis  
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JH4 Sequence (5’à3’) Reference 
VHA (Fw) ARGCCTGGGRCTTCAGTGAAG (Sander et al., 2015) 
VHE (Fw) GTGGAGTCTGGGGGAGGCTTA (Sander et al., 2015) 
JH4_intron (Rev) CTCCACCAGACCTCTCTAGACAGC (Sander et al., 2015) 
JK5   
VK (Fw) GGCTGCAGSTTCAGTGGCAGTGGRTCWGGRAC (Rouaud et al., 2013) 
JK5_PR (Rev) AGCGAATTCAACTTAGGAGACAAAAGAGAGAAC (Rouaud et al., 2013) 
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